Career Highlights

• Member, Board of Directors, Catalyst Biosciences and OX2 Therapeutics 

• Proven healthcare executive with over 25 years of management experience in regenerative medicine, cell and gene therapy, biologics, and medical devices across a wide spectrum of therapeutic areas

• Successful corporate entrepreneur specializing in the commercialization of new products and solutions

• Skilled in medical devices, biotechnology, start-ups, biopharmaceuticals, and product development

  • Shire: Vice President: New product gene therapy, neuroscience, oncology, ophthalmology

  • Baxalta: Vice President, Global Franchise Head: blood disorders

  • Baxter International: Vice President, Lead BAX855 and gene therapy - Biosciences Division; Vice President, regenerative medicine